ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 2190 for the last semiannual is 321.53 M HKD, and it's 23.54% higher compared to the previous semiannual. The net income of H2 23 is -46.69 M HKD.